Lloyd Mackenzie

1.9k total citations
24 papers, 1.5k citations indexed

About

Lloyd Mackenzie is a scholar working on Molecular Biology, Biotechnology and Organic Chemistry. According to data from OpenAlex, Lloyd Mackenzie has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Biotechnology and 8 papers in Organic Chemistry. Recurrent topics in Lloyd Mackenzie's work include Enzyme Production and Characterization (11 papers), Carbohydrate Chemistry and Synthesis (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Lloyd Mackenzie is often cited by papers focused on Enzyme Production and Characterization (11 papers), Carbohydrate Chemistry and Synthesis (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Lloyd Mackenzie collaborates with scholars based in Canada, United Kingdom and United States. Lloyd Mackenzie's co-authors include Stephen G. Withers, R. Antony J. Warren, Qingping Wang, G.J. Davies, Martin Schülein, Annabelle Varrot, A.M. Brzozowski, Mirosława Dauter, Andrea Vasella and Brian W. Matthews and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

Lloyd Mackenzie

20 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd Mackenzie Canada 17 994 726 613 391 177 24 1.5k
Seung Seo Lee United Kingdom 17 791 0.8× 340 0.5× 519 0.8× 136 0.3× 123 0.7× 32 1.2k
Renée Mosi Canada 14 411 0.4× 405 0.6× 262 0.4× 97 0.2× 208 1.2× 18 1.1k
Liuqing Wen China 21 1.1k 1.1× 126 0.2× 788 1.3× 158 0.4× 157 0.9× 63 1.4k
Wing L. Sung Canada 19 959 1.0× 336 0.5× 265 0.4× 299 0.8× 45 0.3× 38 1.3k
John W. Perich Australia 24 1.3k 1.3× 103 0.1× 459 0.7× 86 0.2× 42 0.2× 75 1.9k
Roger F. Sherwood United Kingdom 19 959 1.0× 280 0.4× 180 0.3× 85 0.2× 17 0.1× 38 1.5k
Dietmar Lang Germany 14 1.9k 1.9× 166 0.2× 120 0.2× 216 0.6× 28 0.2× 22 2.1k
Colin D. Reynolds United Kingdom 17 584 0.6× 156 0.2× 247 0.4× 150 0.4× 54 0.3× 43 1.1k
Clarence T. T. Wong Hong Kong 22 1.2k 1.2× 109 0.2× 603 1.0× 220 0.6× 10 0.1× 56 1.6k
Zhimeng Wu China 22 1.1k 1.1× 95 0.1× 235 0.4× 149 0.4× 49 0.3× 101 1.5k

Countries citing papers authored by Lloyd Mackenzie

Since Specialization
Citations

This map shows the geographic impact of Lloyd Mackenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Mackenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Mackenzie more than expected).

Fields of papers citing papers by Lloyd Mackenzie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Mackenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Mackenzie. The network helps show where Lloyd Mackenzie may publish in the future.

Co-authorship network of co-authors of Lloyd Mackenzie

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd Mackenzie. A scholar is included among the top collaborators of Lloyd Mackenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd Mackenzie. Lloyd Mackenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Packham, Graham, Beatriz Valle‐Argos, Freda K. Stevenson, et al.. (2018). Abstract 1871: Development of pelorol analogues to activate the SHIP1 lipid phosphatase; a novel paradigm to suppress B-cell receptor signaling in human B-cell cancers. Cancer Research. 78(13_Supplement). 1871–1871.
2.
Stenton, Grant R., Curtis Harwig, Csaba Szabó, et al.. (2017). AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis. British Journal of Pharmacology. 174(18). 3045–3057. 15 indexed citations
3.
Nickel, J. Curtis, Blair Egerdie, Edward L. Davis, et al.. (2016). A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome. The Journal of Urology. 196(3). 747–754. 31 indexed citations
5.
Leaker, Brian, Peter J. Barnes, Brian O’Connor, et al.. (2014). The effects of the novel SHIP1 activator AQX‐1125 on allergen‐induced responses in mild‐to‐moderate asthma. Clinical & Experimental Allergy. 44(9). 1146–1153. 34 indexed citations
6.
Knott, Brandon C., Majid Haddad Momeni, Michael F. Crowley, et al.. (2013). The Mechanism of Cellulose Hydrolysis by a Two-Step, Retaining Cellobiohydrolase Elucidated by Structural and Transition Path Sampling Studies. Journal of the American Chemical Society. 136(1). 321–329. 154 indexed citations
7.
Stenton, Grant R., Lloyd Mackenzie, Patrick Tam, et al.. (2012). Characterization of AQX‐1125, a small‐molecule SHIP1 activator. British Journal of Pharmacology. 168(6). 1519–1529. 41 indexed citations
9.
Meimetis, Labros G., Matt Nodwell, Lu Yang, et al.. (2012). Synthesis of SHIP1‐Activating Analogs of the Sponge Meroterpenoid Pelorol. European Journal of Organic Chemistry. 2012(27). 5195–5207. 33 indexed citations
10.
Stenton, Grant R., et al.. (2011). AQX-1125, a Modulator of the SHIP1/PI3K Pathway, Suppresses Chemotaxis and Inflammation. Journal of Allergy and Clinical Immunology. 127(2). AB65–AB65. 2 indexed citations
11.
Johnson, Steven, Pietro Roversi, Timothy R. Hughes, et al.. (2007). High-resolution structures of bacterially expressed soluble human CD59. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 63(8). 648–652. 20 indexed citations
12.
Juers, D.H., Tom D. Heightman, Andrea Vasella, et al.. (2001). A Structural View of the Action ofEscherichia coli(lacZ) β-Galactosidase,. Biochemistry. 40(49). 14781–14794. 193 indexed citations
13.
Johnson, Philip E., Emmanuel Brun, Lloyd Mackenzie, Stephen G. Withers, & Lawrence P. McIntosh. (1999). The cellulose-binding domains from Cellulomonas fimi β-1,4-glucanase CenC bind nitroxide spin-labeled cellooligosaccharides in multiple orientations. Journal of Molecular Biology. 287(3). 609–625. 39 indexed citations
14.
Sulzenbacher, Gerlind, Lloyd Mackenzie, Keith S. Wilson, et al.. (1999). The Crystal Structure of a 2-Fluorocellotriosyl Complex of the Streptomyces lividans Endoglucanase CelB2 at 1.2 Å Resolution,. Biochemistry. 38(15). 4826–4833. 54 indexed citations
15.
16.
Vocadlo, David J., Lloyd Mackenzie, Shouming He, G. Zeikus, & Stephen G. Withers. (1998). Identification of Glu-277 as the catalytic nucleophile of Thermoanaerobacterium saccharolyticum β-xylosidase using electrospray MS. Biochemical Journal. 335(2). 449–455. 33 indexed citations
17.
Davies, G.J., Lloyd Mackenzie, Annabelle Varrot, et al.. (1998). Snapshots along an Enzymatic Reaction Coordinate:  Analysis of a Retaining β-Glycoside Hydrolase,. Biochemistry. 37(34). 11707–11713. 206 indexed citations
18.
Mackenzie, Lloyd, et al.. (1997). Identification of Glu-330 as the Catalytic Nucleophile of Candida albicans Exo-β-(1,3)-glucanase. Journal of Biological Chemistry. 272(6). 3161–3167. 50 indexed citations
19.
Mackenzie, Lloyd, et al.. (1997). Enzymatic synthesis of disaccharides using Agrobacterium sp. β-glucosidase. Carbohydrate Research. 305(3-4). 371–381. 46 indexed citations
20.
Mackenzie, Lloyd, G.J. Davies, Martin Schülein, & Stephen G. Withers. (1997). Identification of the Catalytic Nucleophile of Endoglucanase I from Fusarium oxysporum by Mass Spectrometry. Biochemistry. 36(19). 5893–5901. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026